Constanze Hantel
Dresden, SN 01307, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications
Evaluation of Curcumin as a Supplement to Improve Mitotane Effects on Adrenocortical Carcinoma.
Journal: Cells
Published: May 18, 2026
IGF2R: a new player in the IGF2 loop sustaining adrenocortical carcinogenesis.
Journal: Cell communication and signaling : CCS
Published: February 18, 2026
[68Ga]Ga-DOTATATE uptake in pheochromocytoma/paraganglioma predicts SSTR2 expression by immunohistochemistry: Strongest uptake in head and neck paraganglioma.
Journal: European journal of nuclear medicine and molecular imaging
Published: December 22, 2025
Corrigendum to "FGF/FGFR inhibitors downmodulate c-Myc oncoprotein and hamper the growth of adrenocortical carcinoma" [Biomed. Pharmacother. 192 (2025) 118677].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 23, 2025
GSK3i combinatorial treatments affect CDK4/6 and compensatory pathways in 3D preclinical models of pancreatic neuroendocrine tumors.
Journal: Biology open
Published: November 18, 2025
Pan-CDK and PLK1 inhibitors as a novel approach for targeted treatment of adrenocortical carcinomas.
Pan-CDK and PLK1 inhibitors as a novel approach for targeted treatment of adrenocortical carcinomas.
Journal: European journal of endocrinology
Published: October 16, 2025
Personalized Drug Screening and Risk Assessment in Patient-Derived Gastroenteropancreatic Neuroendocrine Neoplasms.
Journal: The Journal of clinical endocrinology and metabolism
Published: October 15, 2025
Rising Incidence of Neuroendocrine Neoplasms in Northern Switzerland-Data From the Cancer Registry.
Journal: Journal of the Endocrine Society
Published: September 25, 2025
A novel 2D and 3D model for primary adrenocortical carcinoma of advanced and metastasized stage co-secreting cortisol, aldosterone, testosterone, 18-oxocortisol and 18-hydroxycortisol.
Journal: Endocrine-related cancer
Published: September 24, 2025
Quality of life in patients with pheochromocytoma and paraganglioma: influence of tumor type, genetics and surgical resection.
Journal: European journal of endocrinology
Published: August 25, 2025
FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and hampers the growth of adrenocortical carcinoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 18, 2025
Paltusotine versus octreotide: different effects on radioligand uptake in neuroendocrine tumours.
Journal: Endocrine oncology (Bristol, England)
Published: April 27, 2025
Last Updated: 09/26/2026